- Home
- SGMO vs IMMR Comparison
SGMO vs IMMR Comparison
Compare SGMO & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- IMMR
- Stock Information
- Founded
- SGMO 1995
- IMMR 1993
- Country
- SGMO United States
- IMMR United States
- Employees
- SGMO N/A
- IMMR N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- IMMR Computer peripheral equipment
- Sector
- SGMO Health Care
- IMMR Technology
- Exchange
- SGMO Nasdaq
- IMMR Nasdaq
- Market Cap
- SGMO 242.0M
- IMMR 272.7M
- IPO Year
- SGMO 2000
- IMMR 1999
- Fundamental
- Price
- SGMO $1.07
- IMMR $8.48
- Analyst Decision
- SGMO Buy
- IMMR Strong Buy
- Analyst Count
- SGMO 6
- IMMR 1
- Target Price
- SGMO $5.17
- IMMR $13.50
- AVG Volume (30 Days)
- SGMO 3.8M
- IMMR 405.1K
- Earning Date
- SGMO 03-12-2025
- IMMR 03-06-2025
- Dividend Yield
- SGMO N/A
- IMMR 4.48%
- EPS Growth
- SGMO N/A
- IMMR 57.07
- EPS
- SGMO N/A
- IMMR 2.04
- Revenue
- SGMO $52,291,000.00
- IMMR $163,133,000.00
- Revenue This Year
- SGMO N/A
- IMMR $988.71
- Revenue Next Year
- SGMO N/A
- IMMR $288.32
- P/E Ratio
- SGMO N/A
- IMMR $4.15
- Revenue Growth
- SGMO N/A
- IMMR 338.21
- 52 Week Low
- SGMO $0.30
- IMMR $6.54
- 52 Week High
- SGMO $3.18
- IMMR $13.94
- Technical
- Relative Strength Index (RSI)
- SGMO 37.60
- IMMR 48.21
- Support Level
- SGMO $1.07
- IMMR $8.14
- Resistance Level
- SGMO $1.24
- IMMR $8.80
- Average True Range (ATR)
- SGMO 0.09
- IMMR 0.24
- MACD
- SGMO 0.02
- IMMR 0.04
- Stochastic Oscillator
- SGMO 5.71
- IMMR 57.79
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About IMMR Immersion Corporation
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.